1. Polyphyllin I inhibits invasion and epithelial-mesenchymal transition via CIP2A/PP2A/ERK signaling in prostate cancer
   Xuewen Liu et al, 2018, International Journal of Oncology CrossRef
2. Cucurbitacin B induces inhibitory effects via CIP2A/PP2A/Akt pathway in glioblastoma multiforme
   Shanshan Qin et al, 2018, Molecular Carcinogenesis CrossRef
3. Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A
   Qiuyue Huang et al, 2017, Oncology Reports CrossRef
4. Brevilin A Induces Cell Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma
   Rui Liu et al, 2019, Frontiers in Pharmacology CrossRef
5. Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae)
   Serhat Sezai Ҫiҫek et al, 2021, RSC Advances CrossRef
6. Multiple Myeloma Inhibitory Activity of Plant Natural Products
   Karin Jöhrer et al, 2021, Cancers CrossRef
7. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/Adriamycin cells
   Fen Cai et al, 2016, Oncology Reports CrossRef
8. Overexpression of CIP2A is associated with poor prognosis in multiple myeloma
   Xuewen Liu et al, 2017, Signal Transduction and Targeted Therapy CrossRef
9. Ethoxysanguinarine inhibits viability and induces apoptosis of colorectal cancer cells by inhibiting CIP2A
   Lan Jin et al, 2018, International Journal of Oncology CrossRef
10. Arnicolide D, from the herb Centipeda minima, Is a Therapeutic Candidate against Nasopharyngeal Carcinoma
    Rui Liu et al, 2019, Molecules CrossRef
11. Increase in CIP2A expression is associated with cisplatin chemoresistance in gastric cancer
    Juanli Ji et al, 2018, Cancer Biomarkers CrossRef
12. Unraveling the Anticancer Components of Centipeda minima and their Cellular Targets in Human Cancers
    Muhammad Faisal Maqbool et al, 2022, Journal of Biologically Active Products from Nature CrossRef